Life Cycle Management (LCM) Market Strategies and Optimizing revenues

In-detail Table of Contents of Life Cycle Management Strategies Market Research

This research discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, and pricing strategies and so on.

Companies discussed in this research AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma.

Get discount on this research at .

Scope for this research:

·         Introduction of LCM and product life cycle

·         Objectives of LCM and factors impacting the choice of strategies

·         LCM strategies depending on the way of approach

·         Impact of LCM strategies on sales and growth trend of selected products

·         Patent term extension and market exclusivity in the US and Europe

·         LCM strategies of pipeline drugs of key players

·         Keys to successful implementation of LCM strategies

Reasons to buy this research:

·         Identify the key LCM strategies used by most of the pharmaceutical companies

·         Analyze the strategies to increase lifecycle and revenues of a drug

·         Gain an understanding on the implementation of multiple strategies for a single product by including case studies

·         Understand the operational pipeline strategies of key players

Complete research report at .

Research provides:

·         Objectives of Life Cycle Management (LCM)

·         Classification and Benefits of LCM Strategies

·         Strategic Planning for LCM

·         Factors Impacting Choice of LCM Strategies

·         Indication Expansion/Sequencing and Repositioning

·         Patient Subpopulations and Personalized Medicine

·         Pricing Strategy and Tactics

·         Awareness, Brand Loyalty and Service Programs

·         Patent Term Extension and Market Exclusivity